David Wood

David Wood PhD

Senior Associate

Executive Summary

David Wood is a lawyer and patent agent in our Calgary office. David practices intellectual property and regulatory law. David is co-chair of the Borden Ladner Gervais Cannabis Industry Focus Group and his regulatory practice is specific to the Canadian medical cannabis industry.

David has advised licensed producers, pre-license entities, technology companies, and other domestic and foreign participants in the Canadian medical cannabis industry in relation to the Controlled Drugs and Substances Act and its regulations, including the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) and the Narcotic Control Regulations.

David’s intellectual property practice includes:​​

  • drafting and prosecuting patent applications;
  • assessing patentability of technology, validity of patents, and infringement of patents, and other patent-related due diligence;
  • multi-jurisdictional patent portfolio management; and
  • patent litigation.

David has experience with chemical, biochemical, information, and mechanical technologies relating to medical cannabis, medical devices, imaging, oil and gas, and other industries.

During his doctoral work, David characterized a complex between DNA and metal ions using a number of biochemical and biophysical techniques, including surface plasmon resonance spectroscopy, quenching of DNA-tethered fluorophores, and ethidium-based fluorescence assays. David’s education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian medical cannabis industry in relation to both intellectual property and regulatory law.

In addition to his technical background, David’s understanding of the ACMPR and other applicable law, and his familiarity with the Canadian medical cannabis industry and its participants, each add value when advising domestic and foreign clients in relation to developing or licensing technology related to the Canadian medical cannabis industry.

Publications & Presentations

  • Author, "Cannabis oil: Heavy on relief, light on cultural baggage," The Lawyer's Daily, July 21, 2017.
  • Co-Author, "The Fall of the Green Wall: Legalizing Cannabis in Canada," BLG’s Securities and Capital Markets Bulletin, April 2017.
  • Author, "ACMPR: Same as it Ever Was — with More Options for Patients and Licensed Producers," BLG's Securities & Capital Markets Bulletin, August 2016.
  • Presenter, "IP Agreements with Employers and Contractors - Common Pitfalls," BLG Employment Law Mini Symposium, May 11, 2016.
  • Presenter, "Protecting your Intellectual Capital in the Canadian Oil & Gas Industry," Canadian Energy Law Foundation Conference, Jasper, 2012.
  • Contributing Author, Life Sciences and Chemical Patent Practice in Canada: A Practical Guide, 3rd Edition, BLG publication (complimentary copy available upon request), 2011.
  • Wood, D.O. & Lee, J.S., "Investigation of pH-dependent DNA-metal Ion Interactions by Surface Plasmon Resonance," Journal of Inorganic Biochemistry, 2005, 99: 566-574.
  • S.D. Wettig, Wood, D.O., P. Aich, R.J.S. Skinner & J.S. Lee, "Fluorescence Quenching in M-DNA: Formation and Electron Transfer Mechanisms," Journal of Inorganic Biochemistry, 2005, 99: 2093-2101.
  • Wettig, S.D., Wood, D.O. & Lee, J.S., "Thermodynamic Investigation of M-DNA: A Novel Metal Ion-DNA Complex," Journal of Inorganic Biochemistry, Bioch, 2003, 94: 94-99.
  • Wood, D.O., Dinsmore, M.J., Bare, G.A. & Lee, J.S.,  "M-DNA is Stabilized in G●C Tracts of by Incorporation of 5-fluorouracil," Nucleic Acids Research, 2002, 30: 2244-2250.